The mean levels of insulin and C-peptide at each time point in a total of 10 patients were higher and the renal function and cardiac function were improved after MSCs infusion, indicating that transplantation of placenta-MSC represents a simple, safe and effective therapeutic approach for T2D patients with islet cell dysfunction. The gene discussed is INS; the disease is type 2 diabetes mellitus.